TABLE OF CONTENTS
1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF U.S. WOMEN'S HEALTH DIAGNOSTICS MARKET 13
1.4 LIMITATIONS 14
1.5 MARKETS COVERED 15
2 MARKET SEGMENTATION 18
2.1 MARKETS COVERED 18
2.2 U.S. WOMEN'S HEALTH DIAGNOSTICS MARKET: GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 19
2.4 CURRENCY AND PRICING 19
2.5 DBMR TRIPOD DATA VALIDATION MODEL 20
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23
2.7 DBMR MARKET POSITION GRID 24
2.8 MULTIVARIATE MODELING 25
2.9 PRODUCTS LIFELINE CURVE 25
2.10 SECONDARY SOURCES 26
2.11 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 29
5 MARKET OVERVIEW 31
5.1 DRIVERS 33
5.1.1 INCREASING GERIATRIC FEMALE POPULATION 33
5.1.2 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES 34
5.1.3 INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES 35
5.1.4 GROWING NUMBER OF DIAGNOSTIC DEVICE MANUFACTURING COMPANIES 36
5.2 RESTRAINTS 37
5.2.1 PRODUCT RECALLS OF VARIOUS COMPANIES 37
5.2.2 HIGH COST OF DIAGNOSTIC PRODUCTS 37
5.3 OPPORTUNITIES 38
5.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTIC EQUIPMENT 38
5.3.2 STRATEGIC INITIATIVES BY VARIOUS COMPANIES 40
?
5.4 CHALLENGES 41
5.4.1 UNACCEPTABLE HEALTH DISPARITIES IN THE U.S. 41
5.4.2 PRICING PRESSURE 41
6 U.S. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES 43
6.1 OVERVIEW 44
6.2 IMAGING AND MONITORING SYSTEMS 45
6.2.1 MAMMOGRAPHY SYSTEMS 46
6.2.1.1 DEVICE TYPE 46
6.2.1.1.1 DIGITAL MAMMOGRAPHY SYSTEMS 46
6.2.1.1.2 ANALOG MAMMOGRAPHY SYSTEMS 46
6.2.1.1.3 BREAST TOMOSYNTHESIS 46
6.2.1.2 APPLICATION 47
6.2.1.2.1 BREAST CANCER 47
6.2.1.2.2 BREAST LUMPS OR TUMORS 47
6.2.1.2.3 OTHERS 47
6.2.2 ULTRASOUND IMAGING SYSTEMS 48
6.2.2.1 DEVICE TYPE 48
6.2.2.1.1 OB/GYN ULTRASOUND 48
6.2.2.1.2 BREAST ULTRASOUND 48
6.2.2.2 APPLICATION 48
6.2.2.2.1 PREGNANCY SCAN 49
6.2.2.2.2 PELVIC SCAN 49
6.2.2.2.3 ABDOMINAL SCAN 49
6.2.2.2.4 OTHERS 49
6.2.3 MRI SYSTEMS 49
6.2.3.1 APPLICATION 49
6.2.3.1.1 BREAST SCAN 50
6.2.3.1.2 ABDOMEN SCAN 50
6.2.3.1.3 JOINTS SCAN 50
6.2.3.1.4 SPINAL CORD SCAN 50
6.2.3.1.5 CARDIAC SCAN 50
6.2.3.1.6 BLOOD VESSELS SCAN 50
6.2.3.1.7 OTHERS 50
6.2.4 FERTILITY MONITORS 51
6.2.4.1 APPLICATION 51
6.2.4.1.1 OVULATION 51
6.2.4.1.2 INFERTILITY 51
6.2.4.1.3 PREGNANCY 51
6.2.4.1.4 HORMONAL IMBALANCE 51
6.2.4.1.5 OTHERS 51
6.2.5 BONE DENSITOMETER 52
6.2.5.1 APPLICATION 52
6.2.5.1.1 OSTEOPOROSIS 52
6.2.5.1.2 RHEUMATOID ARTHRITIS 52
6.2.5.1.3 BONE-RELATED PROBLEMS 52
6.2.6 NUCLEAR IMAGING SYSTEMS 52
6.2.7 OTHERS 52
6.3 BIOPSY DEVICES 53
6.3.1 BIOPSY FOR CANCER 53
6.3.2 BREAST LUMPS BIOPSY 53
6.3.3 BLOOD BIOPSY 53
6.3.4 LYMPH NODES BIOPSY 53
6.3.5 THYROID BIOPSY 53
6.3.6 SKIN BIOPSY 54
6.3.7 OTHERS 54
6.4 BIOMARKERS 54
6.4.1 ONCOLOGY 54
6.4.2 CARDIOVASCULAR DISEASES 54
6.4.3 OTHERS 54
6.5 REAGENTS AND KITS 55
6.5.1 PREGNANCY AND FERTILITY TESTING KITS 55
6.5.2 BLOOD TEST TYPE KIT 55
6.5.3 HEPATITIS TESTING KIT 55
6.5.4 TUMOR MARKER ELISA TEST KIT 55
6.5.5 STD TEST KITS 56
6.5.6 PAP SMEAR TEST KIT 56
6.5.7 MRSA TESTING KITS 56
6.5.8 HORMONE MARKERS ELISA KITS 56
6.5.9 TUBERCULOSIS TEST KIT 56
6.5.10 OTHERS 56
7 U.S. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER 57
7.1 OVERVIEW 58
7.2 HOSPITALS 58
7.3 CLINICS 58
7.4 DIAGNOSTIC AND IMAGING CENTERS 59
7.5 HOME CARE SETTING 59
8 U.S. IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE 60
8.1 COMPANY SHARE ANALYSIS: MAMMOGRAPHY 60
8.2 COMPANY SHARE ANALYSIS: ULTRASOUND 61
8.3 COMPANY SHARE ANALYSIS: MAGNETIC RESONANCE IMAGING 62
8.4 COMPANY SHARE ANALYSIS: NUCLEAR IMAGING SYSTEM 63
9 SWOT ANALYSIS AND DBMR ANALYSIS 64
9.1 SWOT ANALYSIS 64
9.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 66
10 COMPANY PROFILE 67
10.1 ABBOTT 67
10.1.1 COMPANY SNAPSHOT 67
10.1.2 REVENUE ANALYSIS 67
10.1.3 PRODUCT PORTFOLIO 68
10.1.4 RECENT DEVELOPMENTS 69
10.2 BD 70
10.2.1 COMPANY SNAPSHOT 70
10.2.2 REVENUE ANALYSIS 70
10.2.3 PRODUCT PORTFOLIO 71
10.2.4 RECENT DEVELOPMENTS 72
10.3 BIOMERIEUX SA 73
10.3.1 COMPANY SNAPSHOT 73
10.3.2 REVENUE ANALYSIS 73
10.3.3 PRODUCT PORTFOLIO 74
10.3.4 RECENT DEVELOPMENT 74
10.4 CANON INC. 75
10.4.1 COMPANY SNAPSHOT 75
10.4.2 REVENUE ANALYSIS 75
10.4.3 PRODUCT PORTFOLIO 76
10.4.4 RECENT DEVELOPMENTS 77
10.5 CARDINAL HEALTH 78
10.5.1 COMPANY SNAPSHOT 78
10.5.2 REVENUE ANALYSIS 78
10.5.3 PRODUCT PORTFOLIO 79
10.5.4 RECENT DEVELOPMENT 80
?
10.6 CARESTREAM HEALTH 81
10.6.1 COMPANY SNAPSHOT 81
10.6.2 PRODUCT PORTFOLIO 81
10.6.3 RECENT DEVELOPMENT 82
10.7 COOK 83
10.7.1 COMPANY SNAPSHOT 83
10.7.2 DIVISION PORTFOLIO 83
10.7.3 RECENT DEVELOPMENTS 84
10.8 DANAHER 85
10.8.1 COMPANY SNAPSHOT 85
10.8.2 REVENUE ANALYSIS 85
10.8.3 PRODUCT PORTFOLIO 86
10.8.4 RECENT DEVELOPMENTS 87
10.9 F. HOFFMANN-LA ROCHE LTD. 88
10.9.1 COMPANY SNAPSHOT 88
10.9.2 REVENUE ANALYSIS 88
10.9.3 PRODUCT PORTFOLIO 89
10.9.4 RECENT DEVELOPMENTS 91
10.10 FUJIFILM HOLDINGS CORPORATION 92
10.10.1 COMPANY SNAPSHOT 92
10.10.2 REVENUE ANALYSIS 92
10.10.3 PRODUCT PORTFOLIO 93
10.10.4 RECENT DEVELOPMENTS 94
10.11 GENERAL ELECTRIC 95
10.11.1 COMPANY SNAPSHOT 95
10.11.2 REVENUE ANALYSIS 95
10.11.3 PRODUCT PORTFOLIO 96
10.11.4 RECENT DEVELOPMENT 97
10.12 HITACHI, LTD. 98
10.12.1 COMPANY SNAPSHOT 98
10.12.2 REVENUE ANALYSIS 98
10.12.3 PRODUCT PORTFOLIO 99
10.12.4 RECENT DEVELOPMENTS 100
10.13 HOLOGIC INC 101
10.13.1 COMPANY SNAPSHOT 101
10.13.2 REVENUE ANALYSIS 101
10.13.3 PRODUCT PORTFOLIO 102
10.13.4 RECENT DEVELOPMENTS 103
?
10.14 KONINKLIJKE PHILIPS N.V. 104
10.14.1 COMPANY SNAPSHOT 104
10.14.2 REVENUE ANALYSIS 104
10.14.3 PRODUCT PORTFOLIO 105
10.14.4 RECENT DEVELOPMENTS 109
10.15 MEDGYN PRODUCTS, INC 110
10.15.1 COMPANY SNAPSHOT 110
10.15.2 PRODUCT PORTFOLIO 110
10.15.3 RECENT DEVELOPMENT 111
10.16 NEUROLOGICA CORP. 112
10.16.1 COMPANY SNAPSHOT 112
10.16.2 PRODUCT PORTFOLIO 112
10.16.3 RECENT DEVELOPMENTS 115
10.17 PERKINELMER INC. 116
10.17.1 COMPANY SNAPSHOT 116
10.17.2 REVENUE ANALYSIS 116
10.17.3 PRODUCT PORTFOLIO 117
10.17.4 RECENT DEVELOPMENT 118
10.18 QUEST DIAGNOSTICS INCORPORATED 119
10.18.1 COMPANY SNAPSHOT 119
10.18.2 REVENUE ANALYSIS 119
10.18.3 PRODUCT PORTFOLIO 120
10.18.4 RECENT DEVELOPMENT 120
10.19 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 121
10.19.1 COMPANY SNAPSHOT 121
10.19.2 PRODUCT PORTFOLIO 121
10.19.3 RECENT DEVELOPMENTS 122
10.20 SHIMADZU CORPORATION 123
10.20.1 COMPANY SNAPSHOT 123
10.20.2 REVENUE ANALYSIS 123
10.20.3 PRODUCT PORTFOLIO 124
10.20.4 RECENT DEVELOPEMNT 125
10.21 SIEMENS 126
10.21.1 COMPANY SNAPSHOT 126
10.21.2 REVENUE ANALYSIS 126
10.21.3 PRODUCT PORTFOLIO 127
10.21.4 RECENT DEVELOPMENTS 134
?
10.22 SYSMEX CORPORATION 136
10.22.1 COMPANY SNAPSHOT 136
10.22.2 REVENUE ANALYSIS 136
10.22.3 PRODUCT PORTFOLIO 137
10.22.4 RECENT DEVELOPMENT 137
10.23 THERMO FISHER SCIENTIFIC INC. 138
10.23.1 COMPANY SNAPSHOT 138
10.23.2 REVENUE ANALYSIS 138
10.23.3 PRODUCT PORTFOLIO 139
10.23.4 RECENT DEVELOPMENTS 139
10.24 URIT MEDICAL ELECTRONIC CO., LTD 140
10.24.1 COMPANY SNAPSHOT 140
10.24.2 PRODUCT PORTFOLIO 140
10.24.3 RECENT DEVELOPMENT 141
11 CONCLUSION 142
12 QUESTIONNAIRE 143
13 RELATED REPORTS 148